BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:BWAY • US10501L1061

21.74 USD
-0.41 (-1.85%)
Last: Feb 5, 2026, 10:29 AM
Fundamental Rating

6

Overall BWAY gets a fundamental rating of 6 out of 10. We evaluated BWAY against 186 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. An interesting combination arises when we look at growth and value: BWAY is growing strongly while it also seems undervalued. These ratings could make BWAY a good candidate for value and growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year BWAY was profitable.
  • BWAY had a positive operating cash flow in the past year.
  • BWAY had negative earnings in 4 of the past 5 years.
  • In multiple years BWAY reported negative operating cash flow during the last 5 years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.53%, BWAY belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • The Return On Equity of BWAY (8.92%) is better than 83.87% of its industry peers.
  • With a decent Return On Invested Capital value of 2.75%, BWAY is doing good in the industry, outperforming 69.89% of the companies in the same industry.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Profit Margin, with a value of 12.73%, BWAY belongs to the top of the industry, outperforming 89.25% of the companies in the same industry.
  • The Operating Margin of BWAY (5.78%) is better than 70.97% of its industry peers.
  • BWAY has a Gross Margin of 74.92%. This is amongst the best in the industry. BWAY outperforms 86.02% of its industry peers.
  • BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWAY is destroying value.
  • BWAY has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BWAY has been increased compared to 5 years ago.
  • Compared to 1 year ago, BWAY has a worse debt to assets ratio.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • BWAY has an Altman-Z score of 6.08. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
  • BWAY's Altman-Z score of 6.08 is amongst the best of the industry. BWAY outperforms 82.26% of its industry peers.
  • BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • BWAY has a Debt to FCF ratio of 0.37. This is amongst the best in the industry. BWAY outperforms 91.94% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
  • BWAY's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. BWAY outperforms 66.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 6.08
ROIC/WACC0.32
WACC8.69%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of BWAY (3.19) is comparable to the rest of the industry.
  • A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
  • BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 260.14% over the past year.
  • Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 27.08%.
  • The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 54.11% on average over the next years. This is a very strong growth
  • BWAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.80% yearly.
EPS Next Y77.47%
EPS Next 2Y45.17%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.32 indicates a rather expensive valuation of BWAY.
  • Based on the Price/Earnings ratio, BWAY is valued cheaply inside the industry as 82.26% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BWAY to the average of the S&P500 Index (28.25), we can say BWAY is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 17.43, the valuation of BWAY can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 84.41% of the companies listed in the same industry.
  • BWAY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.32
Fwd PE 17.43
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
  • BWAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BWAY is cheaper than 84.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.22
EV/EBITDA 77.74
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BWAY's earnings are expected to grow with 54.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y45.17%
EPS Next 3Y54.11%

0

5. Dividend

5.1 Amount

  • No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield 0%

BRAINSWAY LTD-ADR

NASDAQ:BWAY (2/5/2026, 10:29:32 AM)

21.74

-0.41 (-1.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11
Earnings (Next)03-09
Inst Owners4.9%
Inst Owner Change1.82%
Ins Owners16.11%
Ins Owner ChangeN/A
Market Cap425.79M
Revenue(TTM)49.09M
Net Income(TTM)6.25M
Analysts85.71
Price Target0.12 (-99.45%)
Short Float %0.8%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)-2.45%
PT rev (3m)4.65%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-1.02%
EPS NY rev (1m)5.17%
EPS NY rev (3m)4.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE 20.32
Fwd PE 17.43
P/S 8.67
P/FCF 23.22
P/OCF 19.12
P/B 6.08
P/tB 6.08
EV/EBITDA 77.74
EPS(TTM)1.07
EY4.92%
EPS(NY)1.25
Fwd EY5.74%
FCF(TTM)0.94
FCFY4.31%
OCF(TTM)1.14
OCFY5.23%
SpS2.51
BVpS3.58
TBVpS3.58
PEG (NY)0.26
PEG (5Y)N/A
Graham Number9.28
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 6.08
F-Score5
WACC8.69%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y77.47%
EPS Next 2Y45.17%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for BWAY stock?

The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 77.47% in the next year.